COVID-19 cases and deaths are surging in Africa as new, more contagious variants of the virus spread to additional countries. Over 175 000 new COVID-19 cases and more than 6200 deaths were reported in Africa in the last week while infections rose by 50% on the continent between 29 December 2020 and 25 January 2021 […]
Read More… from New COVID-19 variants fuelling Africa’s second wave
A new World Health Organization (WHO) road map for neglected tropical diseases (NTDs) proposes ambitious targets and innovative approaches to tackle 20 diseases which affect more than a billion mainly poor people and which thrive in areas where access to quality health services, clean water and sanitation is scarce. Targets include the eradication of dracunculiasis (guinea worm) […]
‘Weak’ and ‘strong’ cells bonding boosts body’s diabetes fight: Scientists have broadened our understanding of how ‘weak’ cells bond with their more mature cellular counterparts to boost the body’s production of insulin – improving our knowledge of the processes leading to type 2 diabetes – a significant global health problem. Type 2 diabetes mellitus occurs when […]
Read More… from ‘Weak’ and ‘strong’ cells bonding boosts body’s diabetes fight
Israel’s Rambam Hospital Joins Efforts to Develop Israeli COVID-19 Vaccine: Israel currently has the highest COVID-19 vaccination rate in the world, and the vast majority of Rambam’s approximately 5,300 employees have already received two doses of the Pfizer vaccine. Earlier this month, the Clinical Trials Unit at Rambam Health Care Campus (in Rambam’s Research & Development […]
Read More… from Israel’s Rambam Hospital Joins Efforts to Develop Israeli COVID-19 Vaccine
Calls on governments to consider the continued use of strict control measures as the only way to reduce the evolution and spread of new COVID-19 variants being made by a group of scientists. The experts in evolution, virology, infectious disease and genomics – at the University of East Anglia (UEA), Earlham Institute and University of […]
Read More… from Continued strict control measures needed to reduce new COVID-19 strains
Research establishes antibiotic potential for cannabis molecule: Synthetic cannabidiol, better known as CBD, has been shown for the first time to kill the bacteria responsible for gonorrhoea, meningitis and legionnaires disease. The research collaboration between The University of Queensland and Botanix Pharmaceuticals Limited could lead to the first new class of antibiotics for resistant bacteria in 60 years. The […]
Sabin Vaccine Institute Funds Researchers to Investigate COVID-19 Misinformation, Design Solutions to Increase Vaccine Acceptance. The Sabin Vaccine Institute (Sabin) announced this week that it has awarded grants to research teams in four countries to explore the social drivers of COVID-19 misinformation, and its impact on routine immunization acceptance and the acceptance of a COVID-19 […]
Read More… from Sabin Vaccine Institute researchers to investigate COVID-19 misinformation
DigiHEST: How we reached 29 countries in two days: The David Nott Foundation recently completed our first digital, live-streamed surgical training course. In December, we piloted our first ever (DigiHEST) course. We transformed an office space, generously provided by Whitby Wood, into an operating theatre and our friends at Redux Content decked the place out […]
Read More… from DigiHEST: How we reached 29 countries in two days
COVID-19: Science scepticism may be reinforced by UK rush to approve vaccines: Former director of public health Professor John Ashton has said that scientific scepticism may be reinforced by the UK’s rush to approve COVID vaccines for public use and the apparent political desire to be the first out of the blocks in contrast to our European neighbours. Writing in the Journal of […]
Read More… from Science scepticism may be reinforced by UK rush to approve vaccines
AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK: The University of Oxford welcomes the news that the UK Government has accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine in the UK. Our vaccine work is progressing quickly. To ensure […]
Read More… from AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK